Shopping Cart
Remove All
Your shopping cart is currently empty
Fasinumab (Anti-Human NGF), a human IgG1κ monoclonal antibody targeting nerve growth factor (NGF), can be used in studies about acute sciatica and knee osteoarthritis (OA). clinical research has demonstrated that Fasinumab achieves statistically significant improvements in both pain and physical function scores when compared to a placebo control group.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $215 | - | In Stock | |
| 5 mg | $563 | - | In Stock | |
| 10 mg | $868 | - | In Stock |
| Description | Fasinumab (Anti-Human NGF), a human IgG1κ monoclonal antibody targeting nerve growth factor (NGF), can be used in studies about acute sciatica and knee osteoarthritis (OA). clinical research has demonstrated that Fasinumab achieves statistically significant improvements in both pain and physical function scores when compared to a placebo control group. |
| Reactivity | Human |
| Application | Functional assay |
| Antibody Type | Monoclonal |
| Endotoxin | <1.0 EU/mg |
| Conjucates | Unconjugated |
| Gene ID | |
| Uniprot ID | |
| Target | NGF/bNGF |
| Molecular Weight | 144.89 kDa |
| Cas No. | 1190239-42-9 |
| Isotype | Human IgG4 kappa |
| Recommended Isotype Control |
| Storage | store at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.